During the past decade, McGuire Research Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McGuire Research Institute" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Mesoblast, Inc." with 3 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McGuire Research Institute" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator, "McGuire Research Institute" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator and "Therion Biologics Corporation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "McGuire Research Institute" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Crohn Disease" (2 trials), "Chronic Hepatitis B" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "McGuire Research Institute" in a lesser frequency.

Most popular intervention types in "McGuire Research Institute" are "Drug" (13 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Etrolizumab" (4 trials), "Etrozulimab" (1 trials), "FK614" (1 trials) and "Lubiprostone" (1 trials). Other intervention names were less common.

The vast majority of trials in "McGuire Research Institute" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "McGuire Research Institute". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in McGuire Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in McGuire Research Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".